SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-203278
Filing Date
2021-06-29
Accepted
2021-06-29 16:12:56
Documents
13
Period of Report
2021-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d169101d8k.htm   iXBRL 8-K 38080
2 EX-10.1 d169101dex101.htm EX-10.1 113273
  Complete submission text file 0001193125-21-203278.txt   301477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pirs-20210625.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20210625_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20210625_pre.xml EX-101.PRE 11404
6 EXTRACTED XBRL INSTANCE DOCUMENT d169101d8k_htm.xml XML 3405
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 211058254
SIC: 2834 Pharmaceutical Preparations